Study on the Level Change and Function of sRAGE and Related Molecules in Patients with Coronary Heart Disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024155

Enrollment

Unknown

Registered

2019-06-28

Start date

2019-08-01

Completion date

Unknown

Last updated

2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

Acute myocardial infarction:No

control subjects:No

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Acute myocardial infarction. 2. People without coronary heart disease (control group). 3. Aged 18-80 years, gender is not limited. 4. Provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Indicators that seriously affect their survival, such as malignant tumors or AIDS. 2. In the last month, she suffered from infectious diseases that needed treatment. 3. Have connective tissue disease. 4. Women who may be pregnant during pregnancy, lactation or within three years. 5. Serious mental illness history or other illnesses can not cooperate with the completion of the entire survey. 6. Participants in clinical trials.

Design outcomes

Secondary

Measure	Time frame
Rehospitalization;myocardial infarction;revascularization;All-cause death;	—

Primary

Measure	Time frame
Soluble advanced glycation end product receptors in plasma;	—

Countries

China

Contacts

Public ContactCaixia Guo

Beijing Tiantan Hospital, Capital Medical University

cxgbb@163.com+86 13691175496

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026